StockWatch
·
ELGI EQUIPMENTS · Q2 FY27 · THE VERDICT

17% Growth, But Profit Growth Stalls—Commodity Inflation Unpriced

Revenue jumped 17.2% to ₹1,134 Cr, but PAT crawled forward just 5.7% to ₹128 Cr. Tariff refunds and delayed price realization mask an underlying margin squeeze that management expects to resolve in H2—but the timing risk is material.

Q2 FY27 resultsELGIEQUIPELGI EQUIPMENTS LTD.12 Nov 2026 · 6 min read
Reported PAT

₹128.3 Cr

+5.7% YoY

Tariff refund (Q2 recognized)

~₹22 Cr

50–60% of ₹40 Cr total

Normalized PAT (ex timing)

~₹106 Cr

Commodity inflation unpriced

The quarter sits at an uncomfortable intersection: headline revenue growth of 17.2% should drive PAT expansion, yet profit crept forward just 5.7%. That gap is the story. Strip out the ₹20–24 Cr in tariff refund benefits recognized this quarter—a timing-driven windfall that management defers another 40–50% to H2—and the organic profit picture is materially softer. Underneath lies a company managing through 5% material cost inflation (cumulative ₹820 Cr year-to-date), most of which hasn't yet found its way into customer prices.

Where the profit came from (and where it stalled)

EBITDA came in at ₹185 Cr, translating to a 16.3% margin—solid in isolation. But the operating profit margin of 16.0% ticked up only 60 basis points quarter-over-quarter, a muted recovery despite the tariff refund cushion. The problem: raw material costs outpaced price realization. Q2 saw ₹170 Cr in material cost inflation alone (following ₹650 Cr in Q1). Management pushed price increases in July–August, but 'those corrections,' as leadership put it, 'haven't yet reflected in Q2 results.' That shifted the timeline to Q3–Q4, a slip from the 'end-Q2' guidance cited on the prior call.

Foreign exchange added approximately 4% of revenue growth (INR/USD and EUR favorable), a structural tailwind that won't repeat if the rupee stabilizes. In sum: margin expansion was masked by a one-time tariff benefit; cost inflation remains unpriced; and FX was atypical. Stripped of these, the quarter shows margin compression not recovery.

Q2 FY27 profit, ₹ Cr
047.995.8143.7128.3Reported PAT22Tariff benefit106Organic PAT
Tariff refund inflates Q2 profit by ~₹22 Cr (~2% of PAT). Normalized for this timing benefit and unpriced commodity costs, organic profit growth is flat to low single-digit YoY.
Management's claims vs. what holds up

17% YoY revenue growth

Supported

₹1,134 Cr vs prior ~₹968 Cr; 17.2% actual

28% EBITDA YoY growth

Unverified

₹185 Cr stated; prior-year absolute not quantified on call

4% of growth from FX, balance volume

Supported

INR/USD and EUR positive; confirmed volume-driven (India 52% growth)

Material costs up ₹170 Cr Q2, ₹650 Cr Q1

Supported

Management explicitly confirmed; YTD cumulative ~₹820 Cr

₹40 Cr tariff refund, 50–60% in Q2

Supported

₹20–24 Cr recognized Q2 in material cost; remainder deferred Q3–Q4

Gross margin recovered ~60bps QoQ

Overstated

OPM 16.0% Q2 vs ~15.4% implied Q1; modest recovery given tariff cushion

What changed on this call

Key shifts from prior quarter
  • Commodity inflation severity: UPGRADED — ₹820 Cr YTD vs assumed 5% inflation

  • Vayu launch trajectory: UPGRADED — Order book 'far exceeding expectations' vs initial guidance

  • Price recovery timing: DOWNGRADED — Now Q3–Q4 FY27, not end-Q2 as prior call indicated

  • Europe and Australia: HOLDING — Reaffirmed 'marginally profitable' FY27 and stabilization; no upgrade

  • US aftermarket: UPGRADED — Service income recovery beginning post-Patton acquisition

How the street is positioned

At ₹561.5 (as of 11 November 2026), the stock trades down 29.7% from its all-time high of ₹798.95, though up 37.5% off its 52-week low of ₹408.25. Technically, it sits above the 20-day moving average (₹540.38) but below the 50-day (₹581.19), suggesting intermediate-term indecision; the RSI of 52.6 confirms neutral territory. Volume is trending upward—a sign of interest, though direction remains unclear.

Institutional positioning is shifting. FII ownership has fallen sharply from 27.62% (Q1 FY26) to 21.90% (Q1 FY27)—a 5.7 percentage-point exodus over 12 months. This tracks the margin pressure and guidance misses. Conversely, domestic institutions (DII) have been adding modestly, from 5.23% to 10.13%, suggesting Indian buyer accumulation at lower prices. Promoter ownership remains steady at 31.19%, showing no insider selling near the highs. The FII retreat is the clearest signal: the market shares the call transcript's own tension—long-term opportunity (Vayu, 18% EBITDA target by 2031) is real, but near-term margin recovery is the gate-keeper, and execution risk is material.

The bull–bear ledger

  • Revenue growth of 17.2% is broad-based and healthy

  • PAT growth of 5.7% reveals unpriced commodity inflation; narrow profit expansion

  • Vayu launch 'outstanding,' order book exceeds expectations

  • Vayu addressable market (25–30% of segment) is known; margin profile is not

  • Tariff refund ₹40 Cr; 50–60% recognized Q2; boost is one-time and timing-driven

  • Price increases pushed July–August but not yet reflected in P&L; Q3–Q4 dependent

  • Long-term 18% EBITDA target (by 2031) is quantified and credible

  • Europe and Australia restructuring on track but remain profitability plays

  • Aftermarket emerging; North America service income recovery beginning

  • FII ownership fallen 5.7pp YoY; domestic institutions accumulating at lower prices

Risks, ranked by how much they should concern a holder

What could derail the thesis, in order of severity

Commodity inflation outpaces 5% assumption; price recovery stalls Q4 or beyond

HIGH

Material costs have already hit ₹820 Cr YTD. If price increases slip further or customer resistance hardens, margin compression will persist and FY28 guidance will fall.

Europe and Australia profitability recovery slower than 'marginally profitable' FY27 target

MEDIUM

Macro headwinds (geopolitical, economies under pressure) could delay restructuring payoff. 50% of growth comes from four geographies; two are under pressure.

Tariff refund balance (40–50% = ₹16–20 Cr) deferred beyond Q4 FY27

MEDIUM

Compounds near-term margin pressure if price recovery also delays. Timing-dependent profit boost disappears from P&L.

Vayu cannibalization and margin profile unknown; low-cost segment may compress returns

MEDIUM

Vayu is intentionally low-margin by design. Scale and pricing strategy unclear. If margins are <10%, overall company EBITDA could face longer-term dilution.

FX headwind if rupee strengthens; 4% of current growth reverses

LOW

Currently a tailwind. Natural hedges likely improve as exports ramp. But a structural shift to rupee strength would reset baseline growth expectations.

What to watch next (the make-or-break catalysts)

Three concrete things that resolve the debate Q3 onwards
  • 1 · Q3 gross margin recovery (the lynchpin)

    Will price increases fully offset material cost inflation? This is the single number that validates or falsifies the thesis. If gross margin expands 100+ bps QoQ in Q3, the market re-rates higher. If it stalls or margins compress further, FY27–28 consensus falls and stock doubles down on margin concerns.

  • 2 · Europe and Australia profitability delivery

    Reaffirmed 'marginally profitable' FY27 and medium-term profit escalation. Track quarterly EBITDA from these regions. If they miss or retreat, restructuring credibility erodes and long-term 18% EBITDA target becomes uncertain.

  • 3 · Vayu ramp and margin trajectory

    Initial launch is 'outstanding.' Watch Q3 order flow, geography coverage (target 35% by September 2026, 100% by January/February 2027), and gross margin per unit. If margins are sub-10%, the market reprices Vayu as a volume story, not a profit story.

This is a company navigating near-term margin pressure with long-term optionality. The Vayu launch and aftermarket opportunity are real, and the 18% EBITDA target by 2031 is credible. But Q2 FY27 exposes the timing risk: 17% revenue growth hasn't translated to profit growth because of unpriced commodity inflation. The quarter is steady execution, not a step-change. Until H2 FY27 delivers on price realization, the market will remain cautious—a stance reflected in the neutral technicals and bifurcated institutional flow.

Hold. The number to track from here is the gross margin in Q3 FY27. That single metric will tell you whether management's confidence on margin recovery is credible or aspirational.

Informational and educational content only. Not investment advice.